{
  "id": 19282046,
  "title": "AbCellera outlines plans to initiate ABCL635 late-stage development in 2027, while citing liquidity for at least the next 3 years",
  "url": "https://urgent.news/2026/11/10/abcellera-outlines-plans-to-initiate-abcl635-late-stage-development",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-10T04:11:50.000Z",
  "source": {
    "name": "Seeking Alpha News",
    "slug": "seeking-alpha-news",
    "url": "https://seekingalpha.com/news/4669470-abcellera-outlines-plans-to-initiate-abcl635-late-stage-development-in-2027-while-citing?feed_item_type=news"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "AbCellera Q3 2026 slides: ABCL635 data sets new VMS efficacy bar",
        "url": "https://urgent.news/2026/11/10/abcellera-q3-2026-slides-abcl635-data-sets-new-vms-efficacy-bar",
        "published": "2026-11-10T00:00:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}